000 | 01334na a2200229 4500 | ||
---|---|---|---|
003 | H12O | ||
005 | 20180417112804.0 | ||
008 | 130622s2012 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_9539 _aRuilope Urioste, Luis Miguel _eNefrología |
||
245 | 0 | 0 |
_aEfficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial _h[artículo] |
260 |
_bClinical Therapeutics, _c2012 |
||
300 | _a34(7):1613-1624. | ||
500 | _aFormato Vancouver: Zhu DL, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial. Clin Ther. 2012;34(7):1613-24. | ||
501 | _aPMID: 22717420 | ||
504 | _aContiene 46 referencias | ||
520 | _aPatients with grade 2 or 3 hypertension may require high-dose combination therapy to achieve blood pressure (BP) targets in a timely manner. | ||
710 |
_986 _aServicio de Nefrología |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/9/pc9869.pdf _ySolicitar documento |
||
942 |
_n0 _2ddc _cART |
||
999 |
_c9869 _d9869 |